The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Applications of carbonic anhydrase inhibitors and activators in therapy
Abstract
Inhibitors and activators of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1) have a large number of applications in therapy. Many types of such new derivatives have been reported recently, together with their potential applications as antiglaucoma, anticancer and anti-osteoporosis agents or for the management of a variety of neurological disorders, among others. Furthermore, some CA isozymes seem to be valuable markers of tumour progression in a variety of tissues and organs. The CA activators, although not clinically exploited up to now, seem to constitute a new revolutionary approach for the treatment of Alzheimer's disease and other neurodegenerative disorders in need of memory therapy. Recent progress in all these areas, as well as in the characterisation of new such enzymes/isozymes isolated in many organisms/tissues and their detailed catalytic/inhibition mechanisms are, reviewed in the present paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biological function for cadmium in marine diatoms
Lane, T. W., & Morel, F. M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090091397 · Cited by 715
Carbonic anhydrase inhibitors and their therapeutic potential
Supuran, C. T., & Scozzafava, A. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.575 · Cited by 549
Self-citationLoncaster, J. A., Harris, A. L., Davidson, S. E., Logue, J. P., Hunter, R. D., Wycoff, C. C., Pastorek, J., Ratcliffe, P. J., Stratford, I. J., & West, C. (2001) · PubMed · Cited by 482
Chia, S. K., Wykoff, C. C., Watson, P. H., Han, C., Leek, R. D., Pastorek, J., Gatter, K. C., Ratcliffe, P., & Harris, A. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3660 · Cited by 432
Giatromanolaki, A. N., Koukourakis, M. I., Sivridis, E., Pastorek, J., Wykoff, C. C., Gatter, K. C., & Harris, A. L. (2001) · PubMed · Cited by 374
Whittington, D. A., Waheed, A., Ulmasov, B., Shah, G. N., Grubb, J. H., Sly, W. S., & Christianson, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161301298 · Cited by 335
Kimber, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1407 · Cited by 289
Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
Parkkila, S., Rajaniemi, H., Parkkila, A.-K., Kivelä, J., Waheed, A., Pastoreková, S., Pastorek, J., & Sly, W. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040554897 · Cited by 278
Carbonic anhydrase inhibitors: Sulfonamides as antitumor agents?
Supuran, C. T., Briganti, F., Tilli, S., Chegwidden, W. R., & Scozzafava, A. (2001) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(00)00288-1 · Cited by 277
Self-citationBriganti, F., Mangani, S., Orioli, P., Scozzafava, A., Vernaglione, G., & Supuran, C. T. (1997) · Biochemistry · doi:10.1021/bi970760v · Cited by 277
Self-citation
Cited by
Supuran, C. T., Scozzafava, A., & Casini, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10025 · Cited by 1,449
Self-citationAlterio, V., Di Fiore, A., D’Ambrosio, K., Supuran, C. T., & De Simone, G. (2012) · Chemical Reviews · doi:10.1021/cr200176r · Cited by 1,238
Self-citationKrishnamurthy, V. M., Kaufman, G. K., Urbach, A. R., Gitlin, I., Gudiksen, K. L., Weibel, D. B., & Whitesides, G. M. (2008) · Chemical Reviews · doi:10.1021/cr050262p · Cited by 761
Pastorekova, S., Parkkila, S., Pastorek, J., & Supuran, C. T. (2004) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756360410001689540 · Cited by 662
Self-citationProtease inhibitors of the sulfonamide type: Anticancer, antiinflammatory, and antiviral agents
Supuran, C. T., Casini, A., & Scozzafava, A. (2003) · Medicinal Research Reviews · doi:10.1002/med.10047 · Cited by 431
Self-citationAbbate, F., Casini, A., Owa, T., Scozzafava, A., & Supuran, C. T. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.09.062 · Cited by 262
Self-citationMishra, C. B., Tiwari, M., & Supuran, C. T. (2020) · Medicinal Research Reviews · doi:10.1002/med.21713 · Cited by 260
Self-citationThe Design of Inhibitors for Medicinally Relevant Metalloproteins
Jacobsen, F. E., Lewis, J. A., & Cohen, S. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600204 · Cited by 132
Innocenti, A., Zimmerman, S., Ferry, J., Scozzafava, A., & Supuran, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.06.073 · Cited by 50
Metadata
- Authors
- Supuran, C. T., & Scozzafava, A.
- Venue
- Expert Opinion on Therapeutic Patents
- Publisher
- Informa Healthcare
- Published
- 2002-02
- Volume
- 12
- Issue
- 2
- Pages
- 217-242
- ISSN
- 1354-3776 (ISSN-L)
- 1744-7674
- OpenAlex
- W2119482876
- Cited by
- 258
- References
- 48
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.